SYNDICARE: Syncope Decision Aid for Emergency Care

SYNDICARE:晕厥紧急护理决策辅助

基本信息

  • 批准号:
    9265933
  • 负责人:
  • 金额:
    $ 16.96万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-05-01 至 2020-04-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): The objective of this career development plan and proposed research is to develop the principal investigator into an independent clinical investigator to improve the emergency care of syncope patients. Syncope, or transient loss of consciousness, is a common reason to seek emergency department (ED) care. It can be caused by serious cardiac disease but is often a result of a benign etiology. Despite decades of research in this area, there remains a huge variability in the clinical management of these patients. Hospitalization after a non-diagnostic ED evaluation has not been shown to benefit patients and may, in some cases, be harmful. This decision is often made without significant input from patients regarding their wishes or discussion of reasonable alternatives. Shared decision-making is a collaborative process in which patients and physicians make a health care decision together, taking into account the best available evidence and the patient's values and preferences. Shared decision-making is appropriate when more than one medically reasonable management options exists, as in out-patient versus in-patient management of low-risk syncope patients. Decision aids are tools designed to increase patient understanding of treatment options and possible outcomes. Another means to improve emergency syncope care is the application of dissemination and implementation strategies to increase the use of clinical interventions proven to benefit patients. This research proposal has the following three aims: 1) Pilot test and refine a decision aid (named SynDA) using input from patients and providers, 2) Evaluate the effects of using this decision aid in a randomized controlled trial, and 3) Conduct a dissemination and implementation project to identify quality gaps in emergency care and determine their casual factors through qualitative interviews. The results of this research have the potential to positively impact the 1 million patients who present to ED with syncope every year in the United States. The proposed activities will provide the principal investigator with knowledge and skills in the areas of clinical trials, qualitative methods, and dissemination and implementation science in order to develop, evaluate, and implement interventions to improve cardiovascular outcomes for ED syncope patients.
 描述(由申请人提供):本职业发展计划和拟议研究的目标是将主要研究者发展为独立的临床研究者,以改善晕厥患者的急诊护理。晕厥或短暂意识丧失是寻求急诊室(艾德)护理的常见原因。它可以由严重的心脏病引起,但通常是良性病因的结果。尽管在这一领域进行了数十年的研究,但这些患者的临床管理仍然存在巨大的差异。在非诊断性艾德评估后住院并没有显示出对患者有益,在某些情况下可能是有害的。这一决定往往是在没有病人的意愿或讨论合理的替代方案的重要投入。共同决策是一个协作过程,患者和医生共同做出医疗保健决策,考虑到最佳可用证据以及患者的价值观和偏好。当存在一种以上医学上合理的管理方案时,共同决策是适当的,如低风险晕厥患者的门诊与住院管理。决策辅助工具是旨在增加患者对治疗方案和可能结果的理解的工具。另一种改善急诊晕厥护理的方法是应用传播和实施策略,以增加已证明对患者有益的临床干预措施的使用。本研究计划有以下三个目的:1)使用患者和提供者的输入进行试点测试和改进决策辅助工具(称为SynDA),2)在随机对照试验中评估使用此决策辅助工具的效果,以及3)进行传播和实施项目,以确定急诊护理的质量差距,并通过定性访谈确定其因果因素。这项研究的结果有可能对美国每年因晕厥而就诊于艾德的100万患者产生积极影响。拟定的活动将为主要研究者提供临床试验、定性方法以及传播和实施科学领域的知识和技能,以开发、评价和实施干预措施,改善艾德晕厥患者的心血管结局。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Marc Probst其他文献

Marc Probst的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Marc Probst', 18)}}的其他基金

Practical Approaches to Care in Emergency Syncope (PACES)
紧急晕厥的实用护理方法 (PACES)
  • 批准号:
    10854193
  • 财政年份:
    2023
  • 资助金额:
    $ 16.96万
  • 项目类别:
Practical Approaches to Care in Emergency Syncope (PACES)
紧急晕厥的实用护理方法 (PACES)
  • 批准号:
    10405916
  • 财政年份:
    2021
  • 资助金额:
    $ 16.96万
  • 项目类别:
Practical Approaches to Care in Emergency Syncope (PACES)
紧急晕厥的实用护理方法 (PACES)
  • 批准号:
    10445071
  • 财政年份:
    2021
  • 资助金额:
    $ 16.96万
  • 项目类别:
PACES: Practical Approaches to Care in Emergency Syncope
PACES:紧急晕厥护理的实用方法
  • 批准号:
    10854051
  • 财政年份:
    2021
  • 资助金额:
    $ 16.96万
  • 项目类别:
Practical Approaches to Care in Emergency Syncope (PACES)
紧急晕厥的实用护理方法 (PACES)
  • 批准号:
    10618317
  • 财政年份:
    2021
  • 资助金额:
    $ 16.96万
  • 项目类别:
SYNDICARE: Syncope Decision Aid for Emergency Care
SYNDICARE:晕厥紧急护理决策辅助
  • 批准号:
    9088757
  • 财政年份:
    2016
  • 资助金额:
    $ 16.96万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.96万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 16.96万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.96万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.96万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.96万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.96万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.96万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 16.96万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 16.96万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 16.96万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了